The inflammatory and cytotoxic effects of a nitric oxide releasing cream on normal skin.
We describe the pro-inflammatory and cytotoxic effects of nitric oxide in vivo in human skin. Nitrite and ascorbic acid were mixed on the skin of 12 normal volunteers, three times daily, to release nitric oxide. Exposure to nitric oxide was varied by randomizing the concentration of nitrite and duration of application. Nitric oxide treated skin showed significant increases in cells expressing CD3, CD4, CD8, CD68, neutrophil elastase, ICAM-1, VCAM-1, nitrosotyrosine, p53, and apoptotic cells compared with skin treated with ascorbic acid alone. There was no significant increase in mast cells. Following application of nitric oxide there were significantly fewer CD1a positive Langerhans cells in the epidermis. These appeared to lose dendritic morphology and migrate from the epidermis. There was no significant difference in staining for Ki-67, a marker related to proliferating cell nuclear antigen, between active and control skin but staining was greater after exposure to higher dose nitric oxide than the low dose. Apoptosis, cytotoxicity, and p53 staining were relatively greater after 48 h exposure than after 24 h. These results suggest that nitric oxide is pro-inflammatory and is toxic to DNA, leading to the accumulation of p53 and subsequent apoptosis. High-dose nitric oxide paradoxically led to a smaller increase in macrophages and T cells than low dose suggesting an immunosuppressive effect of higher levels.
Ormerod
A D
AD
Department of Dermatology, Aberdeen Royal Infirmary, Foresterhill, UK. a.d.ormerod@abdn.ac.uk
Copeland
P
P
Hay
I
I
Husain
A
A
Ewen
S W
SW
D017209:Apoptosis / Q000187:drug effects*; D002455:Cell Division / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007150:Immunohistochemistry; D007249:Inflammation / Q000139:chemically induced*; D018799:Intercellular Adhesion Molecule-1 / Q000096:biosynthesis; D015603:Keratinocytes / Q000187:drug effects; D009569:Nitric Oxide / Q000494:pharmacology*; D012867:Skin / Q000187:drug effects* / Q000473:pathology; D016159:Tumor Suppressor Protein p53 / Q000032:analysis; D019010:Vascular Cell Adhesion Molecule-1 / Q000096:biosynthesis
D016159:Tumor Suppressor Protein p53; D019010:Vascular Cell Adhesion Molecule-1; D018799:Intercellular Adhesion Molecule-1; D009569:Nitric Oxide